Stablepharma
Project Bath, Royaume-Uni
UK company based in Bath developing the StablevaX technology, which aims to make vaccines and injectables stable outside the cold chain. A phase 1 trial is under way on a thermostable tetanus-diphtheria vaccine. A partnership with AFT Pharmaceuticals was announced in January 2026 covering anti-infective and oncology markets.
Gallery
Contact
Is this your project?
Claim this listing to update it yourself.
Something wrong on this page? Request a correction or a removal